1. SAT0070 Baricitinib versus adalimumab in patients with active rheumatoid arthritis: analysis of patients achieving a moderate eular response at week 4. (15th June 2017) Authors: Kvien, TK; Riel, P van; Rubbert-Roth, A; Blanco, R; Liu-Leage, SS; Larsson, E; Lund, H; Lόpez-Romero, P; Zaremba-Pechmann, L; Emery, P Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 794 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗